Bayer AG (FRA:BAYN) has been given a €105.00 ($125.00) price objective by investment analysts at HSBC Holdings plc in a research report issued on Tuesday. The firm presently has a “neutral” rating on the healthcare company’s stock.

Several other analysts also recently commented on the company. UBS AG set a €125.00 ($148.81) target price on Bayer AG and gave the company a “buy” rating in a research note on Tuesday. Jefferies Group LLC set a €137.00 ($163.10) price target on shares of Bayer AG and gave the stock a “buy” rating in a report on Tuesday. Deutsche Bank AG set a €124.00 ($147.62) target price on shares of Bayer AG and gave the company a “buy” rating in a report on Monday. Kepler Capital Markets set a €102.00 ($121.43) target price on shares of Bayer AG and gave the company a “neutral” rating in a report on Monday. Finally, Commerzbank Ag set a €124.00 ($147.62) target price on shares of Bayer AG and gave the company a “buy” rating in a report on Monday. Nine research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company. The company presently has a consensus rating of “Buy” and an average target price of €119.64 ($142.42).

Bayer AG (BAYN) opened at 107.22 on Tuesday. Bayer AG has a 1-year low of €85.72 and a 1-year high of €123.82. The stock’s 50 day moving average is €108.88 and its 200-day moving average is €110.84. The firm has a market cap of €93.51 billion and a P/E ratio of 18.55.

TRADEMARK VIOLATION WARNING: “Bayer AG (BAYN) PT Set at €105.00 by HSBC Holdings plc” was originally posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this story on another domain, it was illegally copied and republished in violation of international copyright and trademark laws. The legal version of this story can be viewed at https://www.thecerbatgem.com/2017/08/31/bayer-ag-bayn-pt-set-at-105-00-by-hsbc-holdings-plc.html.

Bayer AG Company Profile

.

Analyst Recommendations for Bayer AG (FRA:BAYN)

Receive News & Stock Ratings for Bayer AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer AG and related stocks with our FREE daily email newsletter.